Groups II and IV were subcutaneously injected with ISPH
(85 mg/kg b.wt.; dose was fixed based on our previous studies [7-9]) on day-20 and -21 to induce myocardial necrosis.
As for semi-implicit schemes, such as MPS (47) and ISPH
, (71) based on a projection method, differential operator models have been refined for discretizing the source term and Laplacian of PPE as well as for restoring momentum conservation (Khayyer et al, 20 08).
Zhang, "The simulation of a landslide-induced surge wave and its overtopping of a dam using a coupled ISPH
model," Engineering Applications of Computational Fluid Mechanics, vol.
In the search for possible compounds that would inhibit IspH
, Oldfield and his colleagues, including graduate student Weixue Wang, turned to a powerful technique, called electron paramagnetic resonance (EPR), which allows researchers to determine molecular structure.
Shao, "An ISPH
simulation of coupled structure interaction with free surface flows," Journal of Fluids and Structures, vol.
3 January 2011 - US biopharmaceutical company Inspire Pharmaceuticals Inc (NASDAQ: ISPH
) announced today disappointing results from its second Phase III clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis (CF).
Tickers featured: AGN, AMGN, BAY, BIIB, CGTK, CRTX, DVAX, GENZ, ISPH
, MEDI, MOGN, NABI, NRMX, ONXX, PFE, RNVS.
20 December 2010 - US-based biopharmaceutical company Inspire Pharmaceuticals Inc (NASDAQ: ISPH
) announced on Friday that the results from its first Phase III clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM).
Tickers featured: ADRX, AGN, APPX, ATRX, AZN, BGEN, BMY, BRL, BVF, CNCT, DNA, ELN, ENZN, FHRX, FRX, GSK, IMCL, ISPH
, JNJ, KG, KV, MRX, MYL, NOVN, NVAX, PFE, PHA, SEPR, SGP, SHPGY, SKYE, TARO, TEVA, WFHC, WYE.
11 November 2010 - UK IS Pharma plc (LON: ISPH
) said yesterday it has secured GBP12.5m (USD20m/EUR14.6m) gross (GBP12m net of expenses) through the placing of 15,625,000 new ordinary shares at 80 pence per share.
(PAX637) CHRISTY SHAFFER - INSPIRE PHARMACEUTICALS INC (ISPH
3 June 2010 - UK speciality pharmaceutical company IS Pharma plc (LON: ISPH
) reported yesterday a pre-tax profit of GBP2.6m (USD3.8m/EUR3.1m), an increase of 30%, for the fiscal year ended 31 March 2010.